Quantification of porcine circovirus type 2 (PCV-2) within- and between-pen transmission in pigs
PCV-2 transmission is influenced by contact structure that appears worth being taken into account in an epidemic model.
Page 11 of articles about pcv2
Prevalence of porcine reproductive and respiratory syndrome virus and porcine circovirus type 2 in piglets after weaning on a commercial pig farm in Japan
To investigate the transition in concentration of porcine reproductive and respiratory syndrome virus (PRRSV) and porcine circovirus type 2 (PCV2) and antibody for these viruses in serum, serum samples were collected from 29 pigs on weaning day and at 7, 14, 21, 28, 53, 84, and 120 days after weaning.
Porcine parvovirus- and porcine circovirus 2-associated reproductive failure and neonatal mortality in crossbred Indian pigs
Results of this study suggest for the first time occurrence of PPV and coinfection with PCV2 in crossbred Indian pigs affected with reproductive problem and neonatal mortality.
The third European Porcine Circovirus Research Award honours scientists from Spain and Denmark
Diseases associated with PCV2 infection (PCVD) belong to the most devastating diseases in swine worldwide. Fortunately, since a few years, losses attributed to this disease complex can be controlled very effectively by vaccinating piglets.
Infectivity of porcine circovirus type 2 DNA in semen from experimentally-infected boars
It has been demonstrated that PCV2 DNA can be detected in boar semen by PCR; however, the biological relevance of this is unknown.
Intervet/Schering-Plough animal health receives european approval for a single-shot dosage scheme of PORCILIS® PCV
Intervet/Schering-Plough Animal Health today announces that it has received marketing authorization from the European Commission on January 12, 2010 for a single-shot vaccination schedule of its PORCILIS® PCV vaccine against porcine circovirus type 2 (PCV2) infections.
Largest pig producing country China approves novel vaccine against widespread pig disease
Ingelvac CircoFLEX® - first vaccine against Porcine Circovirus Disease approved in China
Genetic resistance to disease – An Introduction
The performance and conformation of the pig (the phenotype) depend on the combined effects of its genetic make-up (the genotype), which is mostly fixed at conception, and the environment, which includes health, nutrition, management, housing and climate.
Spain - New PORCIVIR's website about swine viral infections
PORCIVIR is a project coordinated by CReSA for the study of swine viral diseases that have economic, sanitary and public health repercussions. PORCIVIR has an exclusive website available, in which you will be able to consult any information in relation to the project, including the last publications.
Canada - Change to circovirus vaccine program
The federal government has made changes to its eligibility criteria for the Circovirus Inoculation Program. Applicants deemed to be part of a verifiable production flow will now receive compensation for the vaccination of sows.
Prevention and control of porcine circovirus
We may have some highly efficient vaccines, but we shouldn’t forget that for their application we must obtain good diagnostic information, and that in all cases we should not lose sight of good management and a good control of the concomitant diseases.
Risk and/or triggering factors of porcine circovirus
Between 1995 and 1997, at the beginning of an epizootic called “maladie de l’amagrissement du porcelet” (MAP), it was observed that the farms that were most affected and that had the most losses, generally presented obvious deviations from what we would consider to be a suitable management of the animals and facilities. This is why Dr. François Madec made a list of management practices with the aim of improving the anomalous situation observed.
Swine influenza: epidemiology and emergence of new viruses
The first swine influenza viruses were all H1N1 and were for about 60 years in North America. In the middle 1980’s, there appeared in European pigs H3N2 viruses that were derived originally from humans and had adapted to pigs and were therefore known as human-like H3N2 viruses. These viruses have since appeared in other parts of the world most notably as H3N2 in the USA in 1998. These viruses however contained bits of human, avian and swine viruses and were therefore called triple re-assortants.
Immunology against PCV2: What difference is there between a subclinically affected animal and an animal with porcine circovirus?
Pigs that are not affected by the disease tend to have a quantity of sero-neutralizing (and also total) antibodies against PCV2, which is significantly greater than those that cause disease
PORCILIS PCV swine vaccine against porcine circovirus type 2 infection launched in Europe
Intervet/Schering-Plough Animal Health today announces the introduction in Europe of its PORCILIS PCV vaccine against porcine circovirus type 2 (PCV2) infection. The launch of this new subunit vaccine was celebrated this week with a dedicated scientific event near Lisbon (Portugal), attracting hundreds of veterinarians from all over Europe.